Digital Path Practices Reflected in Latest Checklist Changes

Why It Matters

The update standardizes quality and safety controls as digital pathology scales, protecting patients and guiding lab operations in a fast‑evolving regulatory landscape.

Key Takeaways

• Checklist replaces Telepathology with Digital Pathology Remote Assessment.
• Labs must validate digital pathology systems for clinical diagnostics.
• Remote sites identified in reports using address or code.
• Separate CLIA‑certified sites count as referral laboratories.
• Updates respond to rapid AI algorithm growth in pathology.

Pulse Analysis

Digital pathology has moved from niche research tools to core components of diagnostic workflows, prompting regulators to tighten oversight. The CAP’s 2025 checklist reflects this shift, embedding explicit requirements for system validation, data integrity, and patient‑identification safeguards. By redefining the remote assessment concept and mandating clear site attribution in reports, the organization aims to eliminate ambiguity around where diagnoses are rendered, a critical step as laboratories increasingly outsource image review to off‑site experts.

The revised section, now titled “Digital Pathology Including Remote Data Assessment,” replaces the older telepathology language and expands its scope to cover whole‑slide imaging, AI‑assisted algorithms, and other digital platforms. Laboratories must prove that their digital systems perform equivalently to traditional microscopy, and any remote review location—whether a separate CLIA‑certified lab or a home‑based workstation—must be recorded using a standardized address or coding system. This granular reporting not only supports traceability during audits but also clarifies liability, especially when multiple sites contribute to a single diagnostic report.

Beyond compliance, the checklist signals broader industry momentum toward AI integration and decentralized diagnostics. As pathologists adopt machine‑learning tools for triage, quantification, and decision support, consistent validation standards become essential for maintaining diagnostic accuracy and payer confidence. Labs that proactively align with the new CAP requirements will likely experience smoother accreditation cycles, reduced risk of regulatory findings, and a competitive edge in offering remote, AI‑enhanced services to health systems worldwide.